Oncology Pharmacy News

The Victorian Therapeutics Advisory Group (VicTAG) in conjunction with the Victorian Department of Health and Human Services (DHHS), Australia, are funding a project to develop a Chemotherapy Audit Toolkit to provide health services with an audit tool and an overarching governance framework for chemotherapy prescribing and variation from protocol.

 

The European Association of Hospital Pharmacists has launched the #EAHPShortagesSurvey to improve patient outcomes! 

 

The ISOPP 2018 presentation recordings are available in ISOPP's Virtual Education Resource Library (Virtual Library).

If you attended the 2018 Symposium or have previously purchased Virtual Library access, log in to the ISOPP website and visit the Virtual Library to view the new video presentations. Symposium participants receive complimentary access to the 2018 content for one year!

 

If you haven't already, please complete this short 5 minutes online survey by Friday, November 17, 2017. 

 

Oncology pharmacists are capable of providing medication therapy management (MTM) because of their level of training, practice experiences, and responsibilities. Very little data exist about their current practice, including changing roles in the multidisciplinary team, overall impact, and effects in the education of patients and healthcare professionals. Read more...

 

The Journal of Oncology Pharmacy Practice was recently accepted into the Journal Citation Reports (JCR), and received its first ever Impact Factor in June 2017. This is a great testament to the commitment of the Editors and Editorial Board, who wish to thank the authors and reviewers for their dedication and hard work.

 

These draft guidelines are open for public consultation from 29 May 2017 to 23 June 2017

 

You are invited to participate in an excel formatted survey looking at access to cancer medicines for children in low and middle income countries and the global distribution/variance in costs for these agents.

 

The purpose of the NCCN Chemotherapy Order Templates is to enhance patient safety by allowing you to standardize patient care, reduce medication errors, and anticipate and manage adverse events. The NCCN Templates include systemic therapies such as chemotherapy and immunotherapy (along with information such as dosing, route of administration, and duration of infusion), supportive care recommendations, monitoring parameters, and safety instructions.

 

The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicines and legal actions taken by regulatory authorities across the world.

The WHO Pharmaceuticals Newsletter No 2. 2017 is available here.